Table 2

Survival analyses according to vascular endothelial growth factor (VEGF) indices and vascularity

PatientsIndexDivision of indexnMean survival (days)p Value (log rank test)
*Significant difference.
SCC, squamous cell carcinoma.
AllVEGF percentage<Median3817620.06
≥Median431269
AllVEGF percentageLower tercile2415790.55
Middle tercile271289
Higher tercile301615
AllVEGF intensityScore 1620380.47
Score 2511414
Score 3241539
AllVEGF final score<Median4017130.12
≥Median411294
AllVEGF final scoreLower tercile2415790.88
Middle tercile271459
Higher tercile301458
AllVascularity<Median3812970.20
≥Median431680
SCCVEGF percentage<Median2818230.14
≥Median341404
SCCVascularity<Median2913060.11
≥Median331844
Stage IVEGF percentage<Median2418840.33
≥Median211605
Stage IVascularity<Median2018530.65
≥Median251675
Stage II + IIIaVEGF percentage<Median1415430.17
≥Median22946
Stage II + IIIaVascularity<Median186740.01*
≥Median181685